Pfizer’s Covid-19 Pill Failed Study Testing Its Preventive Use
Paxlovid, authorized to treat high-risk people early in infection, didn’t meaningfully reduce illness in exposed adults Authors: Jared S. Hopkins Apr. 29, 2022 The Wall Street Journal The Covid-19 pill from Pfizer Inc. failed to prevent symptomatic infections in adults who had been exposed to the pandemic virus, a late-stage study found. Pfizer said Friday that the […]